1. Functional assessment of MeCP2 in Rett syndrome and cancers of breast, colon, and prostate
   Somnath Pandey et al, 2017, Biochem. Cell Biol. CrossRef
2. MECP2 expression in gastric cancer and its correlation with clinical pathological parameters
   Jing Zhang et al, 2017, Medicine CrossRef
3. Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials
   Yuan Cheng et al, 2019, Sig Transduct Target Ther CrossRef
4. Methyl CpG binding protein 2 promotes colorectal cancer metastasis by regulating N 6 ‐methyladenosine methylation through methyltransferase‐like 14
   Shuo Wang et al, 2021, Cancer Sci CrossRef
5. Evaluation of Diagnostic and Prognostic Value of hsa_circ_0084927 and Analysis of Associated ceRNA Network in Colorectal Cancer
   Yi Chen et al, 2022, IJGM CrossRef
6. Genomic and regulatory characteristics of significant transcription factors in colorectal cancer metastasis
   Bin Zhou et al, 2018, Sci Rep CrossRef
7. Zinc Finger E-Box Binding Homeobox Family: Non-Coding RNA and Epigenetic Regulation in Gliomas
   Bartosz Lenda et al, 2023, Biomedicines CrossRef
8. The Epigenetic Reader Methyl-CpG-Binding Protein 2 (MeCP2) Is an Emerging Oncogene in Cancer Biology
   Kazem Nejati-Koshki et al, 2023, Cancers CrossRef
9. Role of LEDGF/p75 (PSIP1) in oncogenesis. Insights in molecular mechanism and therapeutic potential
   Muluembet Akele et al, 2024, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
10. The expression of exosomal and cellular miRNAs in predicting oxaliplatin resistance in colorectal cancer cells: an in silico and in vitro study
    Hoda Deli et al, 2025, BMC Cancer CrossRef